El Azzouzi, M.; El Ahanidi, H.; Hafidi Alaoui, C.; Chaoui, I.; Benbacer, L.; Tetou, M.; Hassan, I.; Bensaid, M.; Oukabli, M.; Ameur, A.;
et al. The Evaluation of Vascular Endothelial Growth Factor A (VEGFA) and VEGFR2 Receptor as Prognostic Biomarkers in Bladder Cancer. Diagnostics 2023, 13, 1471.
https://doi.org/10.3390/diagnostics13081471
AMA Style
El Azzouzi M, El Ahanidi H, Hafidi Alaoui C, Chaoui I, Benbacer L, Tetou M, Hassan I, Bensaid M, Oukabli M, Ameur A,
et al. The Evaluation of Vascular Endothelial Growth Factor A (VEGFA) and VEGFR2 Receptor as Prognostic Biomarkers in Bladder Cancer. Diagnostics. 2023; 13(8):1471.
https://doi.org/10.3390/diagnostics13081471
Chicago/Turabian Style
El Azzouzi, Meryem, Hajar El Ahanidi, Chaimae Hafidi Alaoui, Imane Chaoui, Laila Benbacer, Mohammed Tetou, Ilias Hassan, Mounia Bensaid, Mohamed Oukabli, Ahmed Ameur,
and et al. 2023. "The Evaluation of Vascular Endothelial Growth Factor A (VEGFA) and VEGFR2 Receptor as Prognostic Biomarkers in Bladder Cancer" Diagnostics 13, no. 8: 1471.
https://doi.org/10.3390/diagnostics13081471
APA Style
El Azzouzi, M., El Ahanidi, H., Hafidi Alaoui, C., Chaoui, I., Benbacer, L., Tetou, M., Hassan, I., Bensaid, M., Oukabli, M., Ameur, A., Al Bouzidi, A., Attaleb, M., & El Mzibri, M.
(2023). The Evaluation of Vascular Endothelial Growth Factor A (VEGFA) and VEGFR2 Receptor as Prognostic Biomarkers in Bladder Cancer. Diagnostics, 13(8), 1471.
https://doi.org/10.3390/diagnostics13081471
